Skip to main content

Table 2 The comparison between treatment groups and standard group in the duration of oxygen-support and CoV RNA clearance time

From: Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2

 

Standard care (n = 12)

Interferon (n = 44)

LPV/r plus interferon (n = 67)

Total patients (n = 123)

P-value

Oxygen-support duration

13 (7, 24)

13 (8, 16)

11 (7, 22)

12 (8, 19)

0.98

Viral clearance

9 (5, 15)

11 (8, 17)

14 (8, 20)

12 (7, 18)

0.33

  1. Data are median (IQR)